ANALYSIS OF SEPARATE GROUPS OF CARDIAC DRUGS’ ECONOMICS AFFORDABILITY IN UKRAINE IN 2016–2020
DOI:
https://doi.org/10.11603/2312-0967.2021.2.12183Keywords:
cardiovascular diseases, cardiac drugs, adequacy of solvency, affordabilityAbstract
The aim of the work. Analysis of the economic affordability of pharmacotherapeutic group of the II level of anatomical and therapeutic chemical classification - "Cardiac drugs" in the domestic pharmaceutical market in 2016-2020.
Materials and methods. The data of distributors' offers were received on the Morion platform for 2016-2020, the offers of distributors by the group "Cardiac drugs", ATX code C01 were averaged. The analysis of retail prices for drugs of group C01 - cardiac drugs, and separately for group C01E X - Various combined cardiac drugs has been conducted. According to the results of calculations of the price chain index (IP), indicators of solvency adequacy (Cas) and economic affordability (D), general trends in the growth of retail prices of cardiac drugs in Ukraine over the past 5 years have been established and the need for import-substitution of drugs of the study group.
Results and discussion. The highest value of the retail price index during 2016-2020 was characterized by group - C01 A - Cardiac glycosides, the lowest rate of price growth corresponded to group C01 B - Antiarrhythmic drugs. It was found that all pharmacotherapeutic subgroups of group C01 were characterized by an annual decrease in the adequacy of solvency. At the same time, the dynamics of increasing economic affordability by an average of 5% was determined - from 2.46 in 2016 to 2.33 in 2020. It was found that for group C01E X "Different combined cardiac drugs" has showed that the trends persist for the group C01 "Cardiological drugs".
Conclusions. The general tendency to moderate growth of prices has been determined, at the same time the calculated indicators of affordability allowed to determine the dynamics to the gradual growth of economic affordability of cardiac drugs, including group C01E X - Various combined cardiac drugs.
References
On Approval of the State Strategy of State Policy Implementation of Providing the Population with Medicines for the period up to 2025: The Resolution of the Cabinet of Ministers of Ukraine of December, 5, 2018 No. 1022 (Ed. of December 5, 2018). Available from: https://zakon.rada.gov.ua/laws/show/1022-2018-%D0%BF.
World Health Organization. [Electronic resource, Geneva]. Available from: www.who.int/cardiovascular_diseases/ru/
Kotvitska AA, Volkova AV, Kubarieva IV, Korzh YuV, Surikova IO. [Analysis of indicators of physical availability of medicines in the Kharkiv region]. Social Pharmacy: State, Problems and Prospects: Proceedings of the International Scientific and Practical Conference VI. April, 23-24, 2020. Khakriv: NFaU. Available from: https://socpharm.nuph.edu.ua/wp-content/blogs.dir/10/files/2020/05/socialna-farmaciya_materiali-konferenciyi-2020.pdf. Ukrainian.
Huz VS, Zaliska OM, Maksymovych NM. [Retrospective analysis of prescriptions for the treatment of cardiovascular diseases in the program "Affordable Medicines" on the example of a pharmacy]. Farmats zhurn. 2020;75(3): 69-79. DOI: 10.32352/0367-3057.3.20.07. Available from: https://pharmj.org.ua/index.php/journal/article/view/884/829. Ukrainian.
Nemchenko AS, Nazarkina VM, Kurylenko YuYe. [Evaluation of the state of pharmaceutical care for patients with cardiovascular diseases based on the results of frequency analysis of drug prescriptions]. Sotsialna farmatsiia v okhoroni zdorovia. 2018;4(3): 20-6. Available from: https://dspace.nuph.edu.ua/bitstream/123456789/16579/1/141653-304991-1-PB.pdf. Ukrainian.
Available drugs. The Ministry of Health of Ukraine. Available from: https://moz.gov.ua/dostupni-liki
Symonenko NA, Podhaina MV, Nemchenko AS, Shpychak OS. [Retrospective analysis of the pharmaceutical market of cardiac drugs in Ukraine for 2016-2020]. Farmats zhurn. 2021;77(3): 14-24. DOI: 10.32352/0367-3057.3.21.02. Ukrainian.
Evaluation of program “Available drugs” in Ukraine. European Regional Committee of the World Health Organization. Committee of WHO in Ukraine. Originally issued in English by the WHO Regional office for Europe in 2019. 60 s. Available from: http://www.euro.who.int/__data/assets/pdf_file/0019/400429/52308-WHO-Affordable-Medicines-Programme-Ukraine-UKR_low_V7.pdf?ua=1
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Pharmaceutical Review
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal
. - Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).
